Cargando…

Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization

[Image: see text] Covalent labeling of G protein-coupled receptors (GPCRs) by small molecules is a powerful approach to understand binding modes, mechanism of action, pharmacology, and even facilitate structure elucidation. We report the first covalent positive allosteric modulator (PAM) for a class...

Descripción completa

Detalles Bibliográficos
Autores principales: Doornbos, Maarten L. J., Wang, Xuesong, Vermond, Sophie C., Peeters, Luc, Pérez-Benito, Laura, Trabanco, Andrés A., Lavreysen, Hilde, Cid, José María, Heitman, Laura H., Tresadern, Gary, IJzerman, Adriaan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331142/
https://www.ncbi.nlm.nih.gov/pubmed/29494768
http://dx.doi.org/10.1021/acs.jmedchem.8b00051
_version_ 1783387098088210432
author Doornbos, Maarten L. J.
Wang, Xuesong
Vermond, Sophie C.
Peeters, Luc
Pérez-Benito, Laura
Trabanco, Andrés A.
Lavreysen, Hilde
Cid, José María
Heitman, Laura H.
Tresadern, Gary
IJzerman, Adriaan P.
author_facet Doornbos, Maarten L. J.
Wang, Xuesong
Vermond, Sophie C.
Peeters, Luc
Pérez-Benito, Laura
Trabanco, Andrés A.
Lavreysen, Hilde
Cid, José María
Heitman, Laura H.
Tresadern, Gary
IJzerman, Adriaan P.
author_sort Doornbos, Maarten L. J.
collection PubMed
description [Image: see text] Covalent labeling of G protein-coupled receptors (GPCRs) by small molecules is a powerful approach to understand binding modes, mechanism of action, pharmacology, and even facilitate structure elucidation. We report the first covalent positive allosteric modulator (PAM) for a class C GPCR, the mGlu(2) receptor. Three putatively covalent mGlu(2) PAMs were designed and synthesized. Pharmacological characterization identified 2 to bind the receptor covalently. Computational modeling combined with receptor mutagenesis revealed T791(7.29×30) as the likely position of covalent interaction. We show how this covalent ligand can be used to characterize the PAM binding mode and that it is a valuable tool compound in studying receptor function and binding kinetics. Our findings advance the understanding of the mGlu(2) PAM interaction and suggest that 2 is a valuable probe for further structural and chemical biology approaches.
format Online
Article
Text
id pubmed-6331142
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-63311422019-01-17 Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization Doornbos, Maarten L. J. Wang, Xuesong Vermond, Sophie C. Peeters, Luc Pérez-Benito, Laura Trabanco, Andrés A. Lavreysen, Hilde Cid, José María Heitman, Laura H. Tresadern, Gary IJzerman, Adriaan P. J Med Chem [Image: see text] Covalent labeling of G protein-coupled receptors (GPCRs) by small molecules is a powerful approach to understand binding modes, mechanism of action, pharmacology, and even facilitate structure elucidation. We report the first covalent positive allosteric modulator (PAM) for a class C GPCR, the mGlu(2) receptor. Three putatively covalent mGlu(2) PAMs were designed and synthesized. Pharmacological characterization identified 2 to bind the receptor covalently. Computational modeling combined with receptor mutagenesis revealed T791(7.29×30) as the likely position of covalent interaction. We show how this covalent ligand can be used to characterize the PAM binding mode and that it is a valuable tool compound in studying receptor function and binding kinetics. Our findings advance the understanding of the mGlu(2) PAM interaction and suggest that 2 is a valuable probe for further structural and chemical biology approaches. American Chemical Society 2018-03-01 2019-01-10 /pmc/articles/PMC6331142/ /pubmed/29494768 http://dx.doi.org/10.1021/acs.jmedchem.8b00051 Text en Copyright © 2018 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
spellingShingle Doornbos, Maarten L. J.
Wang, Xuesong
Vermond, Sophie C.
Peeters, Luc
Pérez-Benito, Laura
Trabanco, Andrés A.
Lavreysen, Hilde
Cid, José María
Heitman, Laura H.
Tresadern, Gary
IJzerman, Adriaan P.
Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization
title Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization
title_full Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization
title_fullStr Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization
title_full_unstemmed Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization
title_short Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization
title_sort covalent allosteric probe for the metabotropic glutamate receptor 2: design, synthesis, and pharmacological characterization
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331142/
https://www.ncbi.nlm.nih.gov/pubmed/29494768
http://dx.doi.org/10.1021/acs.jmedchem.8b00051
work_keys_str_mv AT doornbosmaartenlj covalentallostericprobeforthemetabotropicglutamatereceptor2designsynthesisandpharmacologicalcharacterization
AT wangxuesong covalentallostericprobeforthemetabotropicglutamatereceptor2designsynthesisandpharmacologicalcharacterization
AT vermondsophiec covalentallostericprobeforthemetabotropicglutamatereceptor2designsynthesisandpharmacologicalcharacterization
AT peetersluc covalentallostericprobeforthemetabotropicglutamatereceptor2designsynthesisandpharmacologicalcharacterization
AT perezbenitolaura covalentallostericprobeforthemetabotropicglutamatereceptor2designsynthesisandpharmacologicalcharacterization
AT trabancoandresa covalentallostericprobeforthemetabotropicglutamatereceptor2designsynthesisandpharmacologicalcharacterization
AT lavreysenhilde covalentallostericprobeforthemetabotropicglutamatereceptor2designsynthesisandpharmacologicalcharacterization
AT cidjosemaria covalentallostericprobeforthemetabotropicglutamatereceptor2designsynthesisandpharmacologicalcharacterization
AT heitmanlaurah covalentallostericprobeforthemetabotropicglutamatereceptor2designsynthesisandpharmacologicalcharacterization
AT tresaderngary covalentallostericprobeforthemetabotropicglutamatereceptor2designsynthesisandpharmacologicalcharacterization
AT ijzermanadriaanp covalentallostericprobeforthemetabotropicglutamatereceptor2designsynthesisandpharmacologicalcharacterization